FDA adds to boxed warning for tumor necrosis factor-alpha blockers
The U.S. Food and Drug Administration has updated the boxed warning tumor necrosis factor-alpha blockers to include the risk of infection from Legionella and…
Web Exclusives
Harvard issues new Healthy Eating Plate
Nutrition experts at the Harvard School of Public Health have issued the Health Eating Plate, a visual guide for eating healthy. Read more and…
Increased risk of congenital anomalies in offspring of nurses working in certain areas
A study of 22,611 nurses found an increased risk of congenital anomalies in the “singleton offspring” of nurses employed in operating rooms, pediatric nursing…
Prostate biopsies can increase risk of hospitalization
Men 65 years or older are more likely to be hospitalized within 30 days after a prostate biopsy than men of the same age…
Our Readers Respond
The truth about high-energy drinks Re “High-energy drinks: What you don’t know could hurt you” (August article available here): I am very impressed with…
FDA approves treatment for hereditary angioedema
The U.S. Food and Drug Administration (FDA) has approved Firazyr (icatibant) Injection for the treatment of acute attacks of hereditary angioedema in people ages…
Hospital patients with chronic diseases at risk for unintentional stoppage of medications
A study in JAMA found that patients with chronic diseases who are admitted to the hospital are at increased risk for unintentional discontinuation of…
FDA approves treatment of non-small cell lung cancer
The U.S. Food and Drug Administration (FDA) has approved Xalkori (crizotinib) to treat patients with late-stage non-small cell lung cancers who express the abnormal…
Lancet study suggests 9/11 firefighters may have higher risk of cancer
The Lancet has published a study that reports a “modest excess of cancer cases” in 9/11 New York City firefighters. The researchers caution that…
FDA approves new melanoma drug
The U.S. Food and Drug Administration (FDA) has approved Zelboraf (vemurafenib) for use in patients with metastatic or unresectable melanoma who have the BRAF…
FDA podcast addresses dangers of long-term, high dosage use of Diflucan during pregnancy
The U.S. Food and Drug Administration (FDA) has released a podcast explaining how long-term, high dosage use of Diflucan during pregnancy may be associated…
FDA publishes REMS list
Access a list of Risk Evaluation and Mitigation Strategies (REMS) required by the U.S. Food and Drug Administration (FDA). Read more..
FDA adds to boxed warning for tumor necrosis factor-alpha blockers
The U.S. Food and Drug Administration has updated the boxed warning tumor necrosis factor-alpha blockers to include the risk of infection from…
Harvard issues new Healthy Eating Plate
Nutrition experts at the Harvard School of Public Health have issued the Health Eating Plate, a visual guide for eating healthy. Read…
Increased risk of congenital anomalies in offspring of nurses working in certain areas
A study of 22,611 nurses found an increased risk of congenital anomalies in the “singleton offspring” of nurses employed in operating rooms,…
Prostate biopsies can increase risk of hospitalization
Men 65 years or older are more likely to be hospitalized within 30 days after a prostate biopsy than men of the…
Our Readers Respond
The truth about high-energy drinks Re “High-energy drinks: What you don’t know could hurt you” (August article available here): I am very…
FDA approves treatment for hereditary angioedema
The U.S. Food and Drug Administration (FDA) has approved Firazyr (icatibant) Injection for the treatment of acute attacks of hereditary angioedema in…
Hospital patients with chronic diseases at risk for unintentional stoppage of medications
A study in JAMA found that patients with chronic diseases who are admitted to the hospital are at increased risk for unintentional…
FDA approves treatment of non-small cell lung cancer
The U.S. Food and Drug Administration (FDA) has approved Xalkori (crizotinib) to treat patients with late-stage non-small cell lung cancers who express…
Lancet study suggests 9/11 firefighters may have higher risk of cancer
The Lancet has published a study that reports a “modest excess of cancer cases” in 9/11 New York City firefighters. The researchers…
FDA approves new melanoma drug
The U.S. Food and Drug Administration (FDA) has approved Zelboraf (vemurafenib) for use in patients with metastatic or unresectable melanoma who have…
FDA podcast addresses dangers of long-term, high dosage use of Diflucan during pregnancy
The U.S. Food and Drug Administration (FDA) has released a podcast explaining how long-term, high dosage use of Diflucan during pregnancy may…
FDA publishes REMS list
Access a list of Risk Evaluation and Mitigation Strategies (REMS) required by the U.S. Food and Drug Administration (FDA). Read more..
Poll
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.